Sherpa Healthcare Partners has led a $30 million Series A for Paq Therapeutics, a Chinese-founded biotech company specializing in treatments based on molecules that enhance the degradation of disease-causing entities.
Sherpa was established by the former healthcare heads at Legend Capital and closed its first US dollar fund at $200 million last year. It was joined in the Series A by Huagai Capital, MSA Capital, and...
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
Best & Less Group (BLG), an Australian baby, kids and womenswear retailer, has raised A$60 million ($44 million) through a domestic IPO, facilitating a partial exit for majority owner Allegro Funds Group.
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.
B Capital Group has hired Sheila Patel, formerly the Singapore-based chairman of Goldman Sachs Asset Management, as a vice president amid a concerted Asian expansion drive.